thiazoles has been researched along with Vascular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, F; Makino, T; Mizawa, M; Shimizu, T | 1 |
| Cho, H; Choe, YS; Choi, YS; Jeon, S; Kang, DR; Ki, CS; Kim, C; Kim, GH; Kim, HJ; Kim, JH; Kim, JS; Kim, ST; Lee, JH; Lee, JM; Lee, KH; Na, DL; Noh, Y; Seo, SW; Weiner, MW; Werring, DJ; Ye, BS; Yoon, CW | 1 |
| Alexopoulos, P; Auer, F; Diehl-Schmid, J; Drzezga, A; Förster, S; Förstl, H; Grimmer, T; Kurz, A; Ortner, M; Perneczky, R; Sorg, C; Yousefi, BH | 1 |
| Chui, HC; DeCarli, C; Jagust, WJ; Kriger, S; Mack, WJ; Madison, CM; Marchant, NL; Reed, BR; Sanossian, N; Villeneuve, S; Weiner, MW; Wirth, M | 1 |
| Asghar, W; Jamali, F | 1 |
| Cho, CH; Cho, HJ; Han, JK; Hur, J; Jun, SI; Kang, HJ; Kim, HS; Kim, JY; Koh, GY; Lee, HS; Lee, HY; Oh, BH; Park, KW; Park, YB; Peters, JM; Yang, HM | 1 |
| Campana, V; Gavotto, A; Moya, M; Palma, J; Simes, J; Spitale, L | 1 |
| Dol, F; Herbert, JM; Laplace, MC; Mares, AM | 1 |
1 review(s) available for thiazoles and Vascular Diseases
| Article | Year |
|---|---|
The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Case-Control Studies; Cyclooxygenase 2 Inhibitors; Humans; Kidney Diseases; Meloxicam; Randomized Controlled Trials as Topic; Risk Factors; Thiazines; Thiazoles; Vascular Diseases | 2015 |
7 other study(ies) available for thiazoles and Vascular Diseases
| Article | Year |
|---|---|
Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
Topics: Adolescent; Anticoagulants; Factor Xa Inhibitors; Humans; Livedo Reticularis; Lower Extremity; Male; Pyridines; Skin; Skin Ulcer; Thiazoles; Thrombosis; Vascular Diseases | 2017 |
Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Brain; Cognition Disorders; Female; Genotype; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Neuropsychological Tests; Prospective Studies; Radionuclide Imaging; Thiazoles; Vascular Diseases | 2013 |
Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Diseases; Middle Aged; Radionuclide Imaging; Thiazoles; Vascular Diseases | 2015 |
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Chi-Square Distribution; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Risk Factors; Thiazoles; Vascular Diseases | 2014 |
Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Topics: Animals; Blood Flow Velocity; Bone Marrow; Cells, Cultured; Corneal Neovascularization; Disease Models, Animal; Endothelial Cells; Female; Hematopoietic Stem Cells; Hindlimb; Humans; Ischemia; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinases; PPAR delta; Proto-Oncogene Proteins c-akt; Stem Cell Transplantation; Thiazoles; Vascular Diseases | 2008 |
Hyperfibrinogenemia in rats treated with meloxicam.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Cyclooxygenase Inhibitors; Endothelium, Vascular; Fibrinogen; Male; Meloxicam; Rats; Thiazines; Thiazoles; Vascular Diseases | 2002 |
Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury.
Topics: Animals; Aorta; Cell Division; Endothelium, Vascular; Hyperplasia; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thiazoles; Vascular Diseases | 1995 |